Irs2 cancer

Author: jigv

August undefined, 2024

WebJan 9, 2024 · To investigate the clinical implications of IRS2 gain/amplification in cancer progression, we analyzed the SCLC dataset that is publicly available via the cBioPortal for Cancer Genomics (http://www.cbioportal.org/msk-impact). IRS2 amplification was … WebMar 4, 2024 · In addition, it was found that IRS2 silencing had an inhibitory effect on the progression of NSCLC, and the upregulation of IRS2 partially impaired the inhibitory effect of miR‐448 in NSCLC.

Activating Mutations of Insulin Receptor Substrate 2 (IRS2) in …

WebJan 24, 2024 · Recent data indicate that IGF1R/IRS signaling is a potential therapeutic target in BCR-ABL1-negative myeloproliferative neoplasms (MPN); in this pathway, IRS2 is involved in the malignant ... WebDec 3, 2015 · 2 Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science ... harbored a mutation in the insulin receptor substrate 2 (IRS2) gene. IRS2 belongs to the IRS family of cytoplasmic adaptor proteins that function as essential signaling intermediates for intracellular signaling pathways to modulate normal … chip and dan heath decisive

Sandra G. - Founder and CEO LESLIE

WebThe IRS2 GD genotype reduced risk of colon cancer, except among those with an IRS1 R allele. No significant associations were seen in analyses of main effects or interactions of these variants and rectal cancer risk. Conclusions: Both IRS1 and IRS2 variants were associated with colon cancer risk independently. WebMay 29, 2015 · In depth analysis revealed that, despite their responses, their tumors demonstrated multiple aberrations in genes including CCND1, CCNE1, FGFR1, MYC, IRS2, MCL1, PIK3CA, PIK3R1, PRKDC, and TP53. The implications of these diverse aberrations for understanding response and resistance are discussed. Case Presentations WebNov 23, 2016 · IRS1 and IRS2 are the best studied members and are shown to have important roles in cell proliferation, survival, migration, metabolism and differentiation, and have been implicated in cancer... chip and dale zipper come home

Therapeutic destruction of insulin receptor substrates for cancer ...

CirRNA circFAM126A Exerts Oncogenic Functions in NSCLC to Upregulate IRS2

WebAug 8, 2024 · The insulin-like growth factor-1 (IGF-1) signaling pathway has been implicated in non-small cell lung cancer (NSCLC) outcomes and resistance to targeted therapies. However, little is known regarding the molecular mechanisms by which this pathway contributes to the biology of NSCLC. The insulin receptor substrate (IRS) proteins are … chip and dale which has red noseWebIn colorectal cancer, the up-regulation of DOK5 and IRS2 was associated with overall survival status, while in liver cancer, up-regulation was associated with increased vascular invasion. On the other hand, the up-regulation of different IGF/insulin signaling components can lead to similar clinical outcomes; in colorectal cancer, the up ... chip and dan heath books

"WebMay 1, 2016 · Jackson and colleagues (Jackson, et al. 1998) observed that IRS2 is widely expressed in breast cancer cell lines and primary breast cancer cells. In breast cancer patients, membrane localization of IRS-2 was associated with reduced overall survival by multivariate analysis (Clark, et al. 2011). " - Irs2 cancer

Irs2 cancer

IRS2 (insulin receptor substrate 2) - atlasgeneticsoncology.org

WebMar 18, 2024 · Breast cancers that do not express the estrogen receptor (ER) or the progesterone receptor (PR) and have no ERBB2 (commonly referred to as human epidermal growth factor receptor 2 [HER2]) amplification are categorized as triple-negative breast cancers (TNBCs) and comprise 10%–20% of all breast cancers ( Dent et al., 2007, … WebApr 11, 2024 · The Arias-Stella reaction is a hormone-related atypical endometrial change characterized by cytomegaly, nuclear enlargement, and hyperchromasia of endometrial glands; typically associated with intrauterine or extrauterine pregnancies or with gestational trophoblastic disease. Although differentiating the Arias-Stella reaction (ASR) from clear …

Did you know?

WebJun 15, 2024 · IRS2 is a cytoplasmic adaptor mediating effects of insulin and IGF-1 receptors and is involved in more aggressive behavior of different cancer types. In agreement with the genomic data, immunohistochemistry of human clinical samples showed increased expression of IRS2 protein in BM. WebApr 19, 2024 · The identification of somatic mutations in IRS2 in 29% of PILC samples is the first report of recurrent IRS2 mutation in any subtype of breast cancer to our knowledge. IRS2 is an adaptor protein for the insulin and IGF-1 receptors, and it mediates their …

http://www.cancerindex.org/geneweb/IRS2.htm WebApr 21, 2024 · A total of 205 ERBB2 aberrations were detected in 175 of the 589 breast cancer cases, revealing an ERBB2 mutation rate of 29.7%. Various mutation types detected from our cohort included CN amplification (n=166), missense mutations (n=14), fusion (n=12), synonymous mutations (n=7), splice-site mutations (n=3), and intronic mutations …

WebJan 9, 2024 · Small cell lung cancer (SCLC) is a fast-growing and malignant cancer that responds well to chemotherapy; however, the survival rate is less than 15% after 2 years of diagnosis. Therefore, novel therapeutic agents for treating SCLC patients need to be evaluated. This study aims to identify the therapeutic targets based on the comprehensive … WebIRS2 INFORMATION. Proteini. Full gene name according to HGNC. Insulin receptor substrate 2. Gene namei. Official gene symbol, which is typically a short form of the gene name, according to HGNC. IRS2. Protein classi. Assigned …

WebThe IR of any CVC-related complication was numerically higher in patients with SBS with cancer vs without cancer (3.44 vs 1.86 cases per 1,000 catheter-days, respectively). Conclusion: Our study quantifies the incidence of complications in patients with CVCs, including those with SBS, in Japan. Keywords: database, epidemiology, prevalence ...

WebMar 1, 2024 · Thus, our findings suggest that Hippo signaling interacts with AKT signaling by regulating IRS2 expression to prevent NAFLD and liver cancer progression and provide evidence that impaired crosstalk between these 2 pathways accelerates NAFLD and liver … chip and damidWebSynonyms [ 1] IRS-2. Insulin receptor substrate 2 (IRS2) is a gene that encodes a protein of the same name that functions in regulating the effects of insulin-like growth factor 1 and insulin by mediating signaling between receptor tyrosine kinases and other associated … grant denyer healthWebJun 15, 2024 · IRS2 is a cytoplasmic adaptor mediating effects of insulin and IGF-1 receptors and is involved in more aggressive behavior of different cancer types. In agreement with the genomic data, immunohistochemistry of human clinical samples … grant dental officeWebFeb 2, 2024 · Background: Recently, we have shown that seven genes, namely GBP5, IRS2, KRT4, LINCOO707, MRPL55, RRS1 and SLC4A11, have prognostic power for the overall survival in ovarian cancer (OC). Methods: We present an analysis on the association of these genes with any phenotypes and mutations indicative of involvement in female cancers … grant denning and associatesWebFeb 5, 2024 · Thus, our findings suggest that Hippo signaling interacts with AKT signaling by regulating IRS2 expression to prevent NAFLD and liver cancer progression and provide evidence that impaired crosstalk between these 2 pathways accelerates NAFLD and liver … grant denyer family feudWebIRS2 mutations identified in pleomorphic invasive lobular carcinoma (PILC) enhance invasion, revealing a role for this signaling adaptor in the aggressive nature of PILC. IRS2 is an adaptor protein that links ALK to neuroblastoma cell survival through the Akt-FoxO3 … chip and dan heath made to stickWebApr 11, 2024 · The mission of the Public Health Genomics is to integrate advances in human genetics into public health research, policy, and programs grant dermody calgary